ClinicalTrials.Veeva

Menu

Merci Registry - Real World Use of the Merci Retrieval System in Acute Ischemic Stroke

Stryker logo

Stryker

Status

Completed

Conditions

Ischemic Stroke

Treatments

Procedure: Mechanical Thrombectomy

Study type

Observational

Funder types

Industry

Identifiers

NCT00478478
INT-REG-001

Details and patient eligibility

About

Post-Market Registry on Use of Merci Retrieval System. Primary data to be collected will include:

  • Post-procedure revascularization success
  • 90-day mRS 0-2
  • 90-day mortality

Full description

The Merci Registry is a prospective multicenter registry with up to 3000 patients enrolled at a maximum of 100 sites.

The registry requires use (at least one pass in the intracranial vasculature) of any Merci Retriever device (X Series, L Series, V Series) in the setting of acute ischemic stroke due to large vessel intracranial occlusion.

Enrollment

1,000 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient with ischemic stroke is treated with a Merci Retriever that is indicated for thrombus removal in ischemic stroke. "Treated" is defined as being when a Merci Retriever is deployed in the neurovasculature of a patient with an ischemic stroke
  • Patient/patient's surrogate provides informed consent and is willing to comply with the protocol requirements and complete required clinical evaluations, or in the absence of informed consent, an IRB/EC approved waiver of consent and executed data use agreement are in place

Exclusion criteria

-There are no exclusion criteria for this protocol

Trial design

1,000 participants in 1 patient group

Acute Ischemic Stroke patients
Description:
Patients presenting with signs and symptoms consistent with a diagnosis of Acute Ischemic Stroke, who are treated with the Merci Retrieval System during a Mechanical Thrombectomy procedure.
Treatment:
Procedure: Mechanical Thrombectomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems